“Protocol for a Pilot Phase IIa Randomized, Placebo-Controlled, Double-Blind, Crossover Study of Umbilical Cord-Derived Mesenchymal Stem Cells (UCMSC) for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS):The MSCell Study”. Principles and Practice of Clinical Research 10, no. 3 (November 28, 2024). Accessed December 5, 2024. https://journal.ppcr.org/index.php/ppcrjournal/article/view/332.